32 related articles for article (PubMed ID: 28028826)
1. A perspective profile of ADCY1 in cAMP signaling with drug-resistance in lung cancer.
Zou T; Liu J; She L; Chen J; Zhu T; Yin J; Li X; Li X; Zhou H; Liu Z
J Cancer; 2019; 10(27):6848-6857. PubMed ID: 31839819
[TBL] [Abstract][Full Text] [Related]
2. Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients.
Kottorou A; Dimitrakopoulos FI; Diamantopoulou G; Kalofonou F; Stavropoulos M; Thomopoulos K; Makatsoris T; Koutras A; Kalofonos H
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980570
[TBL] [Abstract][Full Text] [Related]
3. CUX2 prevents the malignant progression of gliomas by enhancing ADCY1 transcription.
Yao G; Le S; Min S; Gao Z; Cai C; Deng L
Exp Brain Res; 2022 Dec; 240(12):3153-3165. PubMed ID: 36242624
[TBL] [Abstract][Full Text] [Related]
4. VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft models.
Allen V; Coulombe J; Zhao H; Kreps LM; Cook DP; Pryce B; Clemons M; Vanderhyden BC; Gray DA; Addison CL
Br J Cancer; 2022 Jul; 127(1):56-68. PubMed ID: 35318435
[TBL] [Abstract][Full Text] [Related]
5. Survival stratification for colorectal cancer via multi-omics integration using an autoencoder-based model.
Song H; Ruan C; Xu Y; Xu T; Fan R; Jiang T; Cao M; Song J
Exp Biol Med (Maywood); 2022 Jun; 247(11):898-909. PubMed ID: 34904882
[TBL] [Abstract][Full Text] [Related]
6. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses.
Zhang Y; Yang J; Wang X; Li X
Sci Rep; 2021 Oct; 11(1):20441. PubMed ID: 34650124
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DPP10-AS1 exerts anti-tumor effects on colon cancer
Liu G; Zhao H; Song Q; Li G; Lin S; Xiong S
Aging (Albany NY); 2021 Mar; 13(7):9748-9765. PubMed ID: 33744851
[TBL] [Abstract][Full Text] [Related]
8. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
Liu H; Zhang Z; Zhen P; Zhou M
J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
[TBL] [Abstract][Full Text] [Related]
9. Cross-Talk Between the Adenylyl Cyclase/cAMP Pathway and Ca
Sanchez-Collado J; Lopez JJ; Jardin I; Salido GM; Rosado JA
Rev Physiol Biochem Pharmacol; 2021; 179():73-116. PubMed ID: 33398503
[TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis.
Zhang N; Chen W; Gan Z; Abudurexiti A; Hu X; Sang W
Medicine (Baltimore); 2020 May; 99(21):e20470. PubMed ID: 32481352
[TBL] [Abstract][Full Text] [Related]
11. T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma.
Zhong S; Wu B; Li J; Wang X; Jiang S; Hu F; Dou G; Zhang Y; Sheng C; Zhao G; Li Y; Chen Y
Aging (Albany NY); 2019 Oct; 11(20):9043-9059. PubMed ID: 31655798
[TBL] [Abstract][Full Text] [Related]
12. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
13. PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression.
Xie T; Pan S; Zheng H; Luo Z; Tembo KM; Jamal M; Yu Z; Yu Y; Xia J; Yin Q; Wang M; Yuan W; Zhang Q; Xiong J
Cancer Cell Int; 2018; 18():112. PubMed ID: 30123090
[TBL] [Abstract][Full Text] [Related]
14. Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.
Shi X; Zhao Y; He R; Zhou M; Pan S; Yu S; Xie Y; Li X; Wang M; Guo X; Qin R
Oncotarget; 2018 May; 9(36):24248-24259. PubMed ID: 29849937
[TBL] [Abstract][Full Text] [Related]
15. Identification of the potential biomarkers for the metastasis of rectal adenocarcinoma.
Hua Y; Ma X; Liu X; Yuan X; Qin H; Zhang X
APMIS; 2017 Feb; 125(2):93-100. PubMed ID: 28028826
[TBL] [Abstract][Full Text] [Related]
16. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
17. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum.
Varghese S; Burness M; Xu H; Beresnev T; Pingpank J; Alexander HR
Ann Surg Oncol; 2007 Dec; 14(12):3460-71. PubMed ID: 17899288
[TBL] [Abstract][Full Text] [Related]
18. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer.
Pfister DG; Benson AB; Somerfield MR
N Engl J Med; 2004 Jun; 350(23):2375-82. PubMed ID: 15175439
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
